XML 47 R20.htm IDEA: XBRL DOCUMENT
v3.23.3

Basic and Diluted Net Loss per Share | 9 Months Ended
--- | ---
Oct. 31, 2023
Earnings Per Share [Abstract] |
Basic and Diluted Net Loss per Share | Basic and Diluted Net Loss per Share The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and nine months ended October 31, 2023 and 2022:
| Three Months Ended October 31, |  | Nine Months Ended October 31,
| 2023 |  | 2022 |  | 2023 |  | 2022
| (in thousands, except share and per share data)
Numerator: |  |  |  |  |  |  |
Net loss | $ | (158,219) |  |  | $ | (84,480) |  |  | $ | (362,861) |  |  | $ | (266,446) |
Denominator: |  |  |  |  |  |  |
Weighted average common shares outstanding | 376,190,781 |  |  | 339,674,302 |  |  | 360,836,403 |  |  | 337,135,962 |
Less: Weighted average unvested restricted shares and shares subject to repurchase | (7,998) |  |  | (78,917) |  |  | (18,272) |  |  | (98,851) |
Weighted average shares outstanding - Basic and Diluted | 376,182,783 |  |  | 339,595,385 |  |  | 360,818,131 |  |  | 337,037,111 |
Net loss per share - Basic and Diluted | $ | (0.43) |  |  | $ | (0.25) |  |  | $ | (1.01) |  |  | $ | (0.79) |
The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows:
| October 31, 2023 |  | October 31, 2022
2028 Convertible Notes (on an as-converted basis) | 24,999,990 |  |  | 12,483,569 |
Options to purchase common stock | 13,042,440 |  |  | 18,785,716 |
Restricted stock units | 21,609,427 |  |  | 13,030,259 |
Unvested early exercised common stock options | 4,692 |  |  | 67,318 |
Common stock warrants | 34,499,436 |  |  | 34,587,257 |
Employee stock purchase plan | 8,751,276 |  |  | 1,660,491 |
Total potentially dilutive common share equivalents | 102,907,261 |  |  | 80,614,610 |
PRSUs granted were excluded from the above table because the respective stock price targets have not been met as of October 31, 2023.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration